Home -> Law Blog Directory -> Class Action Blogs -> The UCL Practitioner
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Class Action
: The UCL PractitionerOral argument preview: Clayworth v. Pfizer, Inc.
By Kimberly A. Kralowec
This afternoon at 1:30 p.m., the Supreme Court will hear oral argument in Clayworth v. Pfizer, Inc., no. S166435. In that case, the question is whether an intermediate purchaser (of, for example, price-fixed goods) may recover damages under the Cartwright Act or restitution under the UCL. In other words, can the defendant assert a "pass-on" defense if the plaintiff resold the goods and passed on the overcharges? I am planning to attend the argument and provide a report here tomorrow.
Also, a recent article in the Recorder said that Justice Kennard is going to miss a number of upcoming arguments while she recovers from surgery, including this week's arguments:
An avid and persistent questioner, Kennard would still get to participate by viewing videotapes of the arguments, unless the parties refuse to stipulate to her absence. If that happens, Chief Justice Ronald George said he would need to decide on a case-by-case basis whether to continue the matter or appoint a pro tem justice from the appellate courts to hear it instead.
The Clayworth docket indicates that three pro tem justices have been assigned to the case: "Hon. Ignazio J. Ruvolo, CA 1/4 (for Kennard, J.); Hon. Ronald B. Robie, CA 3 (for Chin, J.); Hon. Douglas P. Miller, CA 4/2 (for Corrigan, J.) ."
Full post as published by The UCL Practitioner on May 03, 2010 (boomark / email).
Bextra Product Recall
Find a Bextra Lawyer
Bextra Injury Risks
Bextra Increases Risk of Fatal Heart Attack
Pfizer, Pharmacia
Found Guilty of Medicaid Fraud
Oral HRT
More Than Doubles the Risk of Blood Clots
Blood Clots
Associated with Oral Contraceptives Yaz and Yasmin
Pfizer
Will Pay $975,000 In Clean Air Settlement
Generic Versions
Barr Pharmaceuticals to pay $5.9 million settlement for blocking the sale of oral contraceptives.
Oral Sodium Phosphate
or OSP has allegedly been recalled for acute kidney injury and kidney failure.

Clayworth v. Pfizer: Supreme Court Extends Time For Granting Review
Ice oral argument transcript now available
Argument Preview: Bobby v. Bies
SCOTUSwiki Preview: Kansas v. Colorado








